Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F14%3A33151179" target="_blank" >RIV/61989592:15110/14:33151179 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy
Original language description
The invention relates to a method for determining the sensitivity of patients suffering from a cancer disease to biological therapy based on the inhibition of HER receptor family signaling pathway.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP 2241890 B1
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Apr 9, 2014
Owner name
Univerzita Palackého v Olomouci, Lékařská fakulta; Masarykův onkologický ústav, Brno
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence